Award
National Institutes of Health CX-17-008
Cannabidiol as an Adjunctive to Prolonged Exposure for the Treatment of PTSD
Recipient
VA San Diego Healthcare System in collaboration with UCSD School of Medicine
Awarded
June 03, 2026
Identifier
CX-17-008
A randomized control trial funded by NIH to evaluate CBD as an adjunct to exposure therapy for PTSD in Veterans, conducted by VA San Diego Healthcare System and UCSD School of Medicine.
Description
This project involves a randomized control trial to evaluate the efficacy of Cannabidiol (CBD) as an adjunct to exposure therapy for PTSD among Veterans. The study is conducted by VA San Diego Healthcare System in collaboration with UCSD School of Medicine, funded by NIH grant CX-17-008, with a project timeline from October 1, 2018, to September 30, 2025. The project aims to inform clinical practice and policy, and provides training opportunities in RCT design, psychopharmacology, and biostatistics.